Quick answer: latest quarter results, by ticker or company name

Reported Q: Q4 2024 Rev YoY: -5.8% EPS YoY: +22.5% Move: -1.06%

The Clorox Company

0I0J.L

$118.00 -1.06%

Exchange LSE Sector Consumer Defensive Industry Household Personal Products

Q4 2024

Published: Aug 8, 2024

Company Status Snapshot

Fast view of the latest quarter outcome for 0I0J.L

Reported

Report Date

Aug 8, 2024

Quarter Q4 2024

Revenue

1.90B

YoY: -5.8%

EPS

1.73

YoY: +22.5%

Market Move

-1.06%

Previous quarter: Q3 2024

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

Revenue of $1.90B down 5.8% year-over-year
EPS of $1.73 increased by 22.5% from previous year
Gross margin of 46.2%
Net income of 216.00M
""Despite the challenges we faced this quarter, our strong operational execution and cost management allowed us to enhance our profitability metrics substantially. We are confident in our ability to deliver consistent growth moving forward."" - Linda Rendle, CEO

0I0J.L

The Clorox Company

Period Q4 2024

Currency USD

Report Type Quarterly Earnings

Generated Feb 10, 2026

Executive Summary

The Clorox Company reported its QQ4 2024 results, showcasing a solid recovery with net revenue of $1.903 billion, representing a slight decline of 5.75% year-over-year but an increase of 4.91% quarter-over-quarter. The company's strategic focus on cost management and product innovation contrasted with a challenging retail environment, allowing for operating income to rise by 6.31% year-over-year and net income to increase significantly by 22.73% year-over-year. Furthermore, the diluted EPS surged to $1.73, reflecting an impressive 22.54% increase on a year-over-year basis. Management's commitment to maintaining margin health and enhancing operational efficiencies is evident in the 14.75% quarter-over-quarter improvement in gross profit, suggesting a resilient underlying business model.

Key Performance Indicators

Revenue

Decreasing

1.90B

QoQ: 4.91% | YoY: -5.75%

Gross Profit

Increasing

879.00M

46.19% margin

QoQ: 14.75% | YoY: 1.97%

Operating Income

Increasing

320.00M

QoQ: 36.75% | YoY: 6.31%

Net Income

Increasing

216.00M

QoQ: 523.53% | YoY: 22.73%

EPS

Increasing

1.74

QoQ: 524.39% | YoY: 22.54%

Revenue Trend

Margin Analysis

Financial Highlights

### Revenue Performance
Total Revenue: $1.903 billion (YoY: -5.75%, QoQ: +4.91%)
Gross Profit: $879 million (gross profit margin: 46.19%, YoY: +1.97%, QoQ: +14.75%)
Operating Income: $320 million (operating income margin: 16.82%, YoY: +6.31%, QoQ: +36.75%)
Net Income: $216 million (net income margin: 11.36%, YoY: +22.73%, QoQ: +523.53%)
Diluted EPS: $1.73 (YoY: +22.54%, QoQ: +524.39%)

### Balance Sheet Health
Total Assets: $5.751 billion
Total Liabilities: $5.259 billion
Total Stockholder Equity: $328 million
Current Ratio: 1.031
Debt-to-Equity Ratio: 10.51 (high leverage poses risks)

### Cash Flow Assessment
Net Cash from Operating Activities: $340 million
Free Cash Flow: $259 million (indicative of healthy cash generation)

Income Statement

Metric	Value	YoY Change	QoQ Change
Revenue	1.90B	-5.75%	4.91%
Gross Profit	879.00M	1.97%	14.75%
Operating Income	320.00M	6.31%	36.75%
Net Income	216.00M	22.73%	523.53%
EPS	1.74	22.54%	524.39%

Key Financial Ratios

Gross Profit Margin

Good

46.20%

Gross profit margin is healthy and competitive within industry standards

Operating Profit Margin

Good

16.80%

Operating margin is healthy and competitive within industry standards

Net Profit Margin

Good

11.40%

Net profit margin is healthy and competitive within industry standards

Return on Assets

Fair

3.76%

Return on assets is acceptable but below top-tier companies

Return on Equity

Strong

65.90%

Return on equity demonstrates excellent capital efficiency and value creation

Current Ratio

Adequate

1.03

Current ratio meets minimum requirements but limited cushion

Debt to Equity

High Risk

10.51

Debt-to-equity indicates high leverage and elevated financial risk

P/E Ratio

Fair Value

19.31x

P/E ratio in line with market averages

Price to Book

High Premium

50.87x

Very high premium suggests asset-light business model or lofty expectations

Historical Earnings Comparison

Period	Revenue ($M)	EPS ($)	YoY Growth	Report
Q3 2025	1,668.00	1.50	-8.1%	View
Q2 2025	1,686.00	1.54	-15.3%	View
Q1 2025	1,762.00	0.79	+27.1%	View
Q4 2024	1,903.00	1.73	-5.8%	View
Q3 2024	1,814.00	-0.41	-5.3%	View

The Clorox Company (0I0J.L) Q4 2024 Earnings Report

Company Status Snapshot

Earnings Highlights

Executive Summary

Key Performance Indicators

Revenue Trend

Margin Analysis

Financial Highlights

Income Statement

Key Financial Ratios

Management Insights Available for Members

Peer Comparison Available for Members

Investment Outlook & SWOT Available for Members

Historical Earnings Comparison

More 0I0J.L Quarterly Reports

0I0J.L

0I0J.L

0I0J.L

0I0J.L

Q4 2024 Reports in Consumer Defensive Sector

0R1R.L

Related Financial Data

Sector Analysis: Consumer Defensive

0I0J.L Full Profile

0I0J.L Financial Statements

Earnings Calendar